D. Song

发表

miR-185 Plays an Anti-Hypertrophic Role in the Heart via Multiple Targets in the Calcium-Signaling Pathways

Jin Ock Kim, D. H. Kim, Seong-Eui Hong, 2015, PloS one.

Both Basic and Acidic Amino Acid Residues of IpTxa Are Involved in Triggering Substate of RyR1

D. H. Kim, D. Song, In-Ra Seo, 2011, Journal of biomedicine & biotechnology.

miR-374 promotes myocardial hypertrophy by negatively regulating vascular endothelial growth factor receptor-1 signaling

Jin Ock Kim, D. H. Kim, C. Cho, 2017, BMB reports.

Genome editing-mediated knock-in of therapeutic genes ameliorates the disease phenotype in a model of hemophilia

Seokjoong Kim, D. Song, Hye-Kyung Oh, 2022, Molecular therapy. Nucleic acids.

miR-185 inhibits endoplasmic reticulum stress-induced apoptosis by targeting Na+/H+ exchanger-1 in the heart

Jin Ock Kim, D. H. Kim, D. Song, 2016, BMB reports.

Occurrence of atypical Ca2+ transients in triadin-binding deficient-RYR1 mutants.

D. H. Kim, P. Allen, Eun Hui Lee, 2006, Biochemical and biophysical research communications.

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

Eunji Kim, Daesik Kim, Hee-Yeon Cho, 2017, Nature Communications.

Ryanodine receptor assembly: a novel systems biology approach to 3D mapping.

D. H. Kim, S. Eom, D. Song, 2011, Progress in biophysics and molecular biology.

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy

Seokjoong Kim, Jun Chang, Hyukjin Lee, 2022, Science advances.

CRISPR-Cas9–mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis

Chang Sik Cho, Jin-Soo Kim, Seokjoong Kim, 2019, Science Advances.

High Homology-Directed Repair Using Mitosis Phase and Nucleus Localizing Signal

O. Koo, D. Song, S. Yeom, 2020, International journal of molecular sciences.

The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.

Jin Ock Kim, D. H. Kim, J. Ryu, 2014, The Biochemical journal.

Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice

Seokjoong Kim, H. Doo, G. Kwak, 2019, Nucleic acids research.

In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector.

Seokjoong Kim, Hyukjin Lee, D. Song, 2023, Molecular therapy. Nucleic acids.

Novel Severe Hemophilia A Mouse Model with Factor VIII Intron 22 Inversion

D. Song, S. Yeom, J. Han, 2021, Biology.